Who is sponsoring NCT05491252?

NCT05491252 is sponsored by Shifa Tameer-e-Millat University.

What drugs are being tested in NCT05491252?

Interventions in NCT05491252: PAtient CEntered Self-Management Intervention (PACE-SMI).

What condition does NCT05491252 study?

NCT05491252 studies Type 2 Diabetes.

Is NCT05491252 still recruiting?

NCT05491252 is currently completed. Last updated 11 April 2023.

Last reviewed 2023-04-11 · How we verify

NCT05491252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Controlled Trial of Patient-Centered Self-Management Intervention in Adults With Type 2 Diabetes Mellitus

Completed NA Last updated 11 April 2023

What this trial tests

NA trial testing PAtient CEntered Self-Management Intervention (PACE-SMI) in Type 2 Diabetes in 612 participants. Completed in 17 February 2023.

Timeline

21 April 2022

Primary endpoint
7 February 2023

17 February 2023

Quick facts

Lead sponsor	Shifa Tameer-e-Millat University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	612
Start date	21 April 2022
Primary completion	7 February 2023
Estimated completion	17 February 2023
Sites	4 locations across Pakistan

Drugs / interventions tested

PAtient CEntered Self-Management Intervention (PACE-SMI)

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

Shifa Tameer-e-Millat University

Who can join

18 and older, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Type 2 Diabetes Mellitus (DM) is a serious health problem for Pakistan and around the world due to its increasing prevalence and the risk of adverse health outcomes including kidney failure, heart attack, stroke, leg amputation and blindness. These problems reduce the quality of life of individuals with type 2 DM and increase their financial burden, thereby affecting the national economy. Given its huge health and economic impact, preventing type 2 DM progression and reducing the risk of associated complications requires immediate attention. Evidence suggests that self-management can slow the progression of type 2 DM, minimizes the risk of major complications and hence, lowers health-care costs. The purpose of this study is to test the effectiveness of a patient centered self-management intervention to improve health outcomes in adults with type 2 DM. It is expected that patients receiving this intervention would have improved health outcomes as compared to patients who did not.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of patient-centered self-management intervention on glycemic control, self-efficacy, and self-care behaviors in South Asian adults with type 2 diabetes mellitus: A multicenter randomized controlled trial.
Asmat K, Sivarajan Froelicher E, Dhamani KA, Gul R, et al · · 2024 · cited 5× · PMID 39264007 · DOI 10.1111/1753-0407.13611
A Patient-Centered Self-Management Intervention to Improve Glycemic Control, Self-Efficacy and Self-Care Behaviors in Adults with Type 2 Diabetes Mellitus: A SPIRIT Compliant Study Protocol for Randomized Controlled Trial.
Asmat K, Dhamani K, Froelicher ES, Gul R. · · 2023 · cited 3× · PMID 36760576 · DOI 10.2147/dmso.s385715

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other Shifa Tameer-e-Millat University trials

Trials by the same sponsor.

NCT06947772 — Skill Building Education of Arteriovenous-Fistula Self-Care Behaviors and Quality of Life of Patients on Hemodialysis · NA · not yet recruiting
NCT06415240 — Effect of Facilitated Tucking and Gentle Human Touch on Procedural Pain Among Neonates · NA · recruiting
NCT06034236 — Comparison of Otago Exercises Versus Resistance Training on Functional Performance in Stroke Patients · NA · completed
NCT06034223 — Effect of Proprioceptive Training Using Head Mounted Laser in Chronic Mechanical Neck Pain · NA · completed
NCT05904860 — Effects of Backward vs Forward Gait Training With Auditory Feedback in Patients With Stroke · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05491252 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shifa Tameer-e-Millat University
Last refreshed: 11 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05491252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing